HEARTBEAM INC (BEAT) Fundamental Analysis & Valuation

NASDAQ:BEAT • US42238H1086

Current stock price

1.14 USD
-0.01 (-0.87%)
Last:

This BEAT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. BEAT Profitability Analysis

1.1 Basic Checks

  • BEAT had negative earnings in the past year.
  • BEAT had a negative operating cash flow in the past year.
  • BEAT had negative earnings in each of the past 5 years.
  • In the past 5 years BEAT always reported negative operating cash flow.
BEAT Yearly Net Income VS EBIT VS OCF VS FCFBEAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M

1.2 Ratios

  • BEAT has a Return On Assets of -359.66%. This is amonst the worse of the industry: BEAT underperforms 94.68% of its industry peers.
  • With a Return On Equity value of -807.34%, BEAT is not doing good in the industry: 89.89% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -359.66%
ROE -807.34%
ROIC N/A
ROA(3y)-346.25%
ROA(5y)-278.24%
ROE(3y)-691.67%
ROE(5y)-530.98%
ROIC(3y)N/A
ROIC(5y)N/A
BEAT Yearly ROA, ROE, ROICBEAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K -4K -5K

1.3 Margins

  • BEAT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BEAT Yearly Profit, Operating, Gross MarginsBEAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. BEAT Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, BEAT has more shares outstanding
  • The number of shares outstanding for BEAT has been increased compared to 5 years ago.
  • There is no outstanding debt for BEAT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BEAT Yearly Shares OutstandingBEAT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
BEAT Yearly Total Debt VS Total AssetsBEAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • Based on the Altman-Z score of -21.41, we must say that BEAT is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -21.41, BEAT is doing worse than 89.36% of the companies in the same industry.
  • There is no outstanding debt for BEAT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -21.41
ROIC/WACCN/A
WACCN/A
BEAT Yearly LT Debt VS Equity VS FCFBEAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 1.45 indicates that BEAT should not have too much problems paying its short term obligations.
  • BEAT has a worse Current ratio (1.45) than 79.26% of its industry peers.
  • A Quick Ratio of 1.41 indicates that BEAT should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.41, BEAT is doing worse than 65.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 1.41
BEAT Yearly Current Assets VS Current LiabilitesBEAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. BEAT Growth Analysis

3.1 Past

  • BEAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.07%, which is quite good.
EPS 1Y (TTM)15.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 17.11% on average over the next years. This is quite good.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y12.4%
EPS Next 2Y8.81%
EPS Next 3Y17.11%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BEAT Yearly Revenue VS EstimatesBEAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2023 2026 2027 2028 100M 200M 300M
BEAT Yearly EPS VS EstimatesBEAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. BEAT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BEAT. In the last year negative earnings were reported.
  • Also next year BEAT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BEAT Price Earnings VS Forward Price EarningsBEAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BEAT Per share dataBEAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as BEAT's earnings are expected to grow with 17.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.81%
EPS Next 3Y17.11%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BEAT Dividend Analysis

5.1 Amount

  • No dividends for BEAT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BEAT Fundamentals: All Metrics, Ratios and Statistics

HEARTBEAM INC

NASDAQ:BEAT (4/13/2026, 10:06:15 AM)

1.14

-0.01 (-0.87%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-12
Earnings (Next)05-07
Inst Owners11.11%
Inst Owner Change-0.04%
Ins Owners9.68%
Ins Owner Change-2.47%
Market Cap46.84M
Revenue(TTM)N/A
Net Income(TTM)-21.02M
Analysts81.82
Price Target5.2 (356.14%)
Short Float %12.36%
Short Ratio3.02
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.22%
Min EPS beat(2)-13.71%
Max EPS beat(2)-0.74%
EPS beat(4)1
Avg EPS beat(4)-6%
Min EPS beat(4)-17.65%
Max EPS beat(4)8.09%
EPS beat(8)2
Avg EPS beat(8)-5.92%
EPS beat(12)4
Avg EPS beat(12)-6.89%
EPS beat(16)4
Avg EPS beat(16)-14.45%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.12%
PT rev (3m)10.27%
EPS NQ rev (1m)-1.82%
EPS NQ rev (3m)-5%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-25%
Revenue NY rev (1m)-24.29%
Revenue NY rev (3m)-24.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 18
P/tB 18
EV/EBITDA N/A
EPS(TTM)-0.62
EYN/A
EPS(NY)-0.54
Fwd EYN/A
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS0
BVpS0.06
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -359.66%
ROE -807.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-346.25%
ROA(5y)-278.24%
ROE(3y)-691.67%
ROE(5y)-530.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1500%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.45
Quick Ratio 1.41
Altman-Z -21.41
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
EPS Next Y12.4%
EPS Next 2Y8.81%
EPS Next 3Y17.11%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-28.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.34%
OCF growth 3YN/A
OCF growth 5YN/A

HEARTBEAM INC / BEAT Fundamental Analysis FAQ

What is the fundamental rating for BEAT stock?

ChartMill assigns a fundamental rating of 2 / 10 to BEAT.


Can you provide the valuation status for HEARTBEAM INC?

ChartMill assigns a valuation rating of 0 / 10 to HEARTBEAM INC (BEAT). This can be considered as Overvalued.


Can you provide the profitability details for HEARTBEAM INC?

HEARTBEAM INC (BEAT) has a profitability rating of 0 / 10.


Can you provide the financial health for BEAT stock?

The financial health rating of HEARTBEAM INC (BEAT) is 5 / 10.